These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Escitalopram : a review of its use in the management of major depressive and anxiety disorders. Waugh J, Goa KL. CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392 [Abstract] [Full Text] [Related]
3. [Efficacy and tolerability of escitalopram in anxiety disorders: a review]. Pelissolo A. Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243 [Abstract] [Full Text] [Related]
6. Escitalopram: better treatment for depression is through the looking glass. Malin P, Wengel SP, Burke WJ. Expert Rev Neurother; 2004 Sep; 4(5):769-79. PubMed ID: 15853504 [Abstract] [Full Text] [Related]
7. Clinical pharmacology review of escitalopram for the treatment of depression. Pastoor D, Gobburu J. Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):121-8. PubMed ID: 24289655 [Abstract] [Full Text] [Related]
8. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder. Foster RH, Goa KL. CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224 [Abstract] [Full Text] [Related]
10. The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders. Bareggi SR, Mundo E, Dell'Osso B, Altamura AC. Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):741-53. PubMed ID: 17916059 [Abstract] [Full Text] [Related]
11. The clinical pharmacokinetics of escitalopram. Rao N. Clin Pharmacokinet; 2007 Oct; 46(4):281-90. PubMed ID: 17375980 [Abstract] [Full Text] [Related]
12. Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study. Strawn JR, Mills JA, Schroeder H, Mossman SA, Varney ST, Ramsey LB, Poweleit EA, Desta Z, Cecil K, DelBello MP. J Clin Psychiatry; 2020 Aug 25; 81(5):. PubMed ID: 32857933 [Abstract] [Full Text] [Related]
16. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Lepola UM, Loft H, Reines EH. Int Clin Psychopharmacol; 2003 Jul 25; 18(4):211-7. PubMed ID: 12817155 [Abstract] [Full Text] [Related]
19. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM. Curr Med Res Opin; 2007 Feb 25; 23(2):401-16. PubMed ID: 17288694 [Abstract] [Full Text] [Related]
20. Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model. Montgomery SA, Loft H, Sánchez C, Reines EH, Papp M. Pharmacol Toxicol; 2001 May 25; 88(5):282-6. PubMed ID: 11393591 [Abstract] [Full Text] [Related] Page: [Next] [New Search]